Comparison of Lung Deposition With the Aeroneb Solo Adapter and a Standard Jet Nebulizer by SPECT-CT

NCT ID: NCT02298101

Last Updated: 2015-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aeroneb Solo Adapter is a vibrating-mesh nebulizer Aeroneb Solo combined to a spacer specifically designed for spontaneously breathing patients. This device has not been investigated in vivo yet.

It's known that using a spacer during nebulization improves aerosol delivery. We hypothetized that lung deposition could be highly increased with the Aeroneb Solo Adapter in comparison to a standard jet nebulizer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aeroneb Solo Adapter

Subjects inhaled radiolabelled aerosol via the Aeroneb Solo Adapter

Group Type ACTIVE_COMPARATOR

Technetium-99m - Diethylenetriaminepentaacetic acid

Intervention Type DRUG

Solution placed on the nebulizer reservoir

Aeroneb Solo Adapter

Intervention Type DEVICE

Nebulizer

Planar scintigraphy

Intervention Type OTHER

Imaging technique to investigate whole lung deposition

Single photon emission computed tomography

Intervention Type OTHER

Imaging technique to investigate regional pulmonary deposition

Spirometry

Intervention Type OTHER

FEV1, FVC assessment

Standard Jet Nebulizer

Subjects inhaled radiolabelled aerosol via a standard jet nebulizer, the Opti-Mist Plus Nebulizer

Group Type ACTIVE_COMPARATOR

Technetium-99m - Diethylenetriaminepentaacetic acid

Intervention Type DRUG

Solution placed on the nebulizer reservoir

Opti-Mist Plus Nebulizer

Intervention Type DEVICE

Standard jet nebulizer

Planar scintigraphy

Intervention Type OTHER

Imaging technique to investigate whole lung deposition

Single photon emission computed tomography

Intervention Type OTHER

Imaging technique to investigate regional pulmonary deposition

Spirometry

Intervention Type OTHER

FEV1, FVC assessment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Technetium-99m - Diethylenetriaminepentaacetic acid

Solution placed on the nebulizer reservoir

Intervention Type DRUG

Aeroneb Solo Adapter

Nebulizer

Intervention Type DEVICE

Opti-Mist Plus Nebulizer

Standard jet nebulizer

Intervention Type DEVICE

Planar scintigraphy

Imaging technique to investigate whole lung deposition

Intervention Type OTHER

Single photon emission computed tomography

Imaging technique to investigate regional pulmonary deposition

Intervention Type OTHER

Spirometry

FEV1, FVC assessment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy respiratory function

Exclusion Criteria

* Pulmonary disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires Saint-Luc

Brussels, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

References

Explore related publications, articles, or registry entries linked to this study.

Dugernier J, Hesse M, Vanbever R, Depoortere V, Roeseler J, Michotte JB, Laterre PF, Jamar F, Reychler G. SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study. Pharm Res. 2017 Feb;34(2):290-300. doi: 10.1007/s11095-016-2061-7. Epub 2016 Nov 7.

Reference Type DERIVED
PMID: 27822851 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AeroSpect-01

Identifier Type: -

Identifier Source: org_study_id